Alliance Pharma plc, a pharmaceutical company, engages in improving patient health through the development, supply, and commercialization of a range of medicinal products.
Business Segments
The company operates through two distinct business segments: Consumer Healthcare and Prescription Medicines.
Consumer Healthcare
This segment provides a range of non-prescription products aimed at improving day-to-day health and well-being. This segment encompasses a variety of well-known brands, each met...
Alliance Pharma plc, a pharmaceutical company, engages in improving patient health through the development, supply, and commercialization of a range of medicinal products.
Business Segments
The company operates through two distinct business segments: Consumer Healthcare and Prescription Medicines.
Consumer Healthcare
This segment provides a range of non-prescription products aimed at improving day-to-day health and well-being. This segment encompasses a variety of well-known brands, each meticulously developed and marketed to cater to specific health needs.
Prescription Medicines
This segment constitutes a suite of prescription pharmaceutical products, targeting both chronic and acute medical conditions. By focusing on quality and innovation, the company has successfully penetrated various markets with its prescription offerings, facilitating access to essential medications for healthcare professionals and patients alike.
Performance evaluation across these segments is conducted primarily on the basis of revenue and gross profit metrics, aligning with the company’s strategic objectives and operational efficiencies. This well-defined segmentation enables the company’s leadership to make informed decisions regarding resource allocation, market expansion, and product development, thus optimizing overall performance.
Business Strategy
The company’s business strategy centers on strategic partnerships, and innovation in product development. The company aims to expand its portfolio through selective acquisitions, organic growth initiatives, and collaborations with healthcare providers and other industry stakeholders.
To effectively leverage its strengths, the company prioritizes understanding the evolving needs of patients and healthcare professionals, ensuring that its products and services align with the latest market trends and regulatory requirements. The company remains committed to enhancing its research and development capabilities to support the development of cutting-edge healthcare solutions.
Products and Services
The company offers a range of products and services across its two primary business segments: Consumer Healthcare and Prescription Medicines.
In the Consumer Healthcare segment, the company’s portfolio features popular brands such as Kelo-Cot, a silicone gel used for scar management; Ambere, which supports menopausal health; and Nizoral™, a well-recognized antifungal treatment. These products are designed to address common health concerns and improve the quality of life for consumers.
The Prescription Medicines segment comprises essential therapeutic offerings like Hydromo, a moisturizing treatment for dry skin; Flamma franchise, which caters to epilepsy management; and Forceva, a multivitamin supplement. The company’s prescription medicines aim to provide effective solutions for various medical conditions while ensuring patient safety and adherence to regulations.
Geographical Markets Served
The company serves a broad geographical market, with a significant presence in Europe, the Middle East, Africa, Asia Pacific, China, and the Americas. As of the year ended December 31, 2023, the company reported total revenues from different regions: EMEA and AMER.
Customers
The company serves a diverse customer base, including healthcare professionals, pharmacies, hospitals, and direct consumers. The customer categories range from medical practitioners who prescribe prescription medicines to individuals purchasing consumer healthcare products over the counter. The company has established relationships with major customers, particularly in the Asia-Pacific market, which has shown significant contributions to revenue. The number of customers served continues to grow as the company expands its market presence and improves its distribution channels.
Sales and Marketing
The company employs a multi-channel approach to sales and marketing, leveraging both traditional and digital marketing strategies to achieve its objectives. The company’s marketing efforts include targeted advertising, professional healthcare communications, and strategic partnerships, enabling it to reach both end-users and healthcare providers effectively.
In terms of distribution, the company utilizes a network of wholesalers, distributors, and direct-to-consumer channels, ensuring that products are easily accessible across various markets. This distribution strategy is designed to optimize the availability of its products, thus enhancing consumer access and reinforcing brand loyalty.
History
Alliance Pharma plc was founded in 1996. The company was incorporated in 1996.
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
